VİTAMİN D VE UTERİN PROLAPSUS ARASINDAKİ İLİŞKİ The Association Between Vitamin D and Uterine Prolapse

Year 2020, Volume: 10 Issue: 2, 23 - 27, 08.06.2020

Can Ata Alper İlerı Varol Gülseren Mustafa Kocaer Eftal Taner

Abstract

ÖZET
Amaç: Pelvik organ prolapsusu pelvik organların vajinal duvarlara veya ötesine herniasyonu olarak tanımlanır.
Vitamin D eksikliğinin pelvik taban kas güçsüzlüğüne sebep olduğu düşünülmektedir. Çalışmamızın
amacı uterin prolapsusu olan hastalarda vitamin D eksikliğini ve incelemektir.
Gereç ve Yöntemler: İzmir Tepecik Eğitim ve Araştırma Hastanesi Kadın Hastalıkları ve Doğum Kliniği’nde
Şubat 2015-2016 arasında peri- ve postmenapozal yaşta vajinal değerlendirmede evre 3-4 uterin prolapsusu
saptanan ve opere olan hastalar; kontrol grubu olarak da aynı yaş grubunda herhangi bir jinekolojik durum
nedeniyle opere olan hastalar retrospektif olarak incelendi. Vitamin D metabolizmasını etkileyecek hastalık
veya fekal inkontinans sebebi olabilecek evre 3 kronik böbrek yetmezliği, kronik karaciğer hastalığı, gastric
bypass, kolovajinal fistül ve pelvik radyasyon öyküsü olan kişiler çalışmadan çıkarıldı.olan kişiler çalışmadan
çıkarıldı. Dahil edilen kişilerin yaş, gravida parite, doğum şekli ve 25 (OH) vitamin D, ICS prolapsus evreleri
kaydedildi.
Bulgular: Çalışma kriterlerine uygun 40 hasta ve 40 kişi kontrol olarak kaydedildi. Hasta grubunun 25-OH D
vitamini düzeyleri (9,5±14,0 ng/ml) kontrol grubundan (15,3 ± 20,3 ng/ml) düşük olarak saptandı (p=0,140).
Hasta grubunun 95,0%’i ve kontrol grubunun 77,5%’inde 25-OH D vitamini eksikliği (<20 ng/mL) saptandı
(p=0,024). 25-OH D vitamini eksikliği uterin prolapsus için bağımız risk faktörü olarak saptandı (OR=5.8, 95%
CI=1.0 – 33,3).
Sonuç: Vitamin D eksikliği uterin prolapsus gelişimi için risk faktörü olabilir.
Anahtar Kelimeler: Pelvik organ prolapsusu; Vitamin D; Risk faktörü
ABSTRACT
Aim: Pelvic organ prolapse, the hernniation of the pelvic organs or beyond the vaginal walls. Vitamin D
deficiency appears to be cause for pelvic muscle weakness. The aim of this study is to investigate the lack of
vitamin D in patients with uterine prolapse.
Methods: The records of patients were evaluated retrospectively in peri- and postmenopausal age group
who were diagnosed with ICS stage 3-4 uterine prolapse based on vaginal examination and operated between
February 2015-2016 in Izmir Tepecik Education and Research Hospital Gyneology and Obstetrics clinic.
The files of 40 patients with ICS stage 0 in the peri- and postmenopausal period, whose 25 (OH) vitamin D
were measured at the same time with the patient group and who underwent surgery due to any gynecologic
indication, were evaluated as control group. Women were excluded if they had any medical conditions
known to impair absorption or metabolism of vitamin D, or to be a major cause of fecal incontinence including
Stage ≥3 chronic kidney disease, chronic liver disease, gastric bypass, colovaginal fistula, and pelvic
irradiation.
Results: 40 patients’ and 40 control cases’ data who met the study criteria were recorded. The patient
group had a lower level of 25 (OH) vitamin D (9,5 ± 14,0 ng/ml) than the control group (15,3 ± 20,3 ng/ml).
Furthermore, 25 (OH) vitamin D deficiency (25 [OH] vitamin D level <20 ng/mL) was found in 95,0% of the
patient group and 77,5% of the control group (p=0,024). A 25 (OH) vitamin D level of <20 ng/mL was found
to be the independent risk factor for uterine prolapse (OR=5,8, 95% CI=1,0 – 33,3).
Conclusion: Vitamin D deficiency may be a risk factor in the development of uterine prolapse.
Key words: Pelvic organ prolapse; Vitamin D; Risk factor

Keywords

VİTAMİN D VE UTERİN PROLAPSUS ARASINDAKİ İLİŞKİ The Association Between Vitamin D and Uterine Prolapse

References

• 1. Bump RC, Mattiason A, Bo K: The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175:10-17. 2. Olsen AL, Smith VJ, Bergstrom JO, Colling JC,: Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997 Apr;89(4):501-6. 3. Swift SE.: The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. Am J Obstet Gynecol. 2000;183:277-285. 4. Brown JS, Waetjen LE, Subak LL, Thom DH, Van den Eeden S, Vittinghoff E. Pelvic organ prolapse surgery in the United States, 1997.Am J Obstet Gynecol. 2002 ;186(4):712-6. 5. Bump RC, Norton PA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 1998;25:723. 6. Hendrix SL, Clark A, Nygaard I et al. Pelvic organ prolapse in the Women’s Health İnitiative: gravity and graviditiy. Am J Obstet Gynecol 2002;186:1160. 7. Bischoff-Ferrari HA, Borchers M, Guddat F, Durmuller U, Stahelin HB, Dick W. Vitamin D Receptor Expression in Human Muscle Tissue Decreases with Age. J Bone Miner Res. 2004; 19:265–269. 8. Candace Y. Parker-Autry, Kathryn L. Burgio, and Holly E. Richter. Vitamin D Status – A Clinical Review with Implications for the Pelvic Floor. Int Urogynecol J. 2012 November ; 23(11): 1517–1526. 9. Dallosso HM, McGrother CW, Matthes RU, Donaldson MMK. Nutrient Composition of the Diet and the Development of Overactive Bladder: A Longitudinal Study in Women. Neurourol Urodynam. 2004; 23:204–210. 10. Badalian SS, Rosenbaum PF. Vitamin D and pelvic Floor Disorders in Women: Results from the National Health and Nutrition Examination Survey. Obstet Gynecol. 2010; 115:795–803.